Chemoinformaics analysis of 3,4-Dimethoxystyrene
Molecular Weight | 164.204 | nRot | 3 |
Heavy Atom Molecular Weight | 152.108 | nRig | 7 |
Exact Molecular Weight | 164.084 | nRing | 1 |
Solubility: LogS | -2.755 | nHRing | 0 |
Solubility: LogP | 2.459 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 26.3055 |
nHD | 0 | BPOL | 15.5105 |
QED | 0.682 |
Synth | 1.684 |
Natural Product Likeliness | 0.291 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.029 |
Pgp-sub | 0.393 |
HIA | 0.005 |
CACO-2 | -4.49 |
MDCK | 0.0000205 |
BBB | 0.958 |
PPB | 0.858162 |
VDSS | 1.284 |
FU | 0.147152 |
CYP1A2-inh | 0.958 |
CYP1A2-sub | 0.926 |
CYP2c19-inh | 0.178 |
CYP2c19-sub | 0.891 |
CYP2c9-inh | 0.061 |
CYP2c9-sub | 0.841 |
CYP2d6-inh | 0.017 |
CYP2d6-sub | 0.918 |
CYP3a4-inh | 0.049 |
CYP3a4-sub | 0.528 |
CL | 10.249 |
T12 | 0.829 |
hERG | 0.056 |
Ames | 0.038 |
ROA | 0.053 |
SkinSen | 0.648 |
Carcinogencity | 0.547 |
EI | 0.971 |
Respiratory | 0.258 |
NR-Aromatase | 0.108 |
Antiviral | No |
Prediction | 0.886862 |